SCM
ANIK icon

Sio Capital Management’s Anika Therapeutics ANIK Stock Holding History

Sio Capital Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-40,000
Closed -$1.63M – 74
2021
Q1 		$1.63M Sell
40,000
-25,382
-39% -$963K 0.33% 68
2020
Q4 		$2.96M Sell
65,382
-28,720
-31% -$1.09M 0.61% 56
2020
Q3 		$3.33M Buy
94,102
+58,070
+161% +$2.1M 0.66% 46
2020
Q2 		$1.36M Buy
+36,032
New +$1.19M 0.4% 56

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sio Capital Management's ANIK Position: Q2 2021 in Review

Sio Capital Management sold out of Anika Therapeutics (ANIK) in Q2 2021, closing a stake of 40,000 shares — an estimated $1.63M sold.

Sio Capital Management first reported a position in ANIK in Q2 2020 and held it in 4 quarters. The position peaked at $3.33M in Q3 2020. 139 funds tracked by Wall St. Rank hold ANIK as of Q2 2021.

  • Sio Capital Management reported no remaining Anika Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Sio Capital Management sold 40,000 Anika Therapeutics shares in Q2 2021, an estimated $1.63M.
  • Sio Capital Management first reported a position in Anika Therapeutics in Q2 2020 and held it in 4 quarters.
  • Sio Capital Management's Anika Therapeutics position peaked at $3.33M in Q3 2020.
  • 139 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2021.

Based on Sio Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.